Epinephrine Market Share

  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Epinephrine Market Share

North American Market Forecast   

The North America epinephrine market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the escalating count of patients suffering from respiratory diseases such as asthma, coupled with the rapidly expanding population in the region. According to a health survey conducted between 2018 - 2020, in the United States, the surge of asthma cases in young individuals aged 18+ years reached 21,030,480 which denotes nearly 8.3% growth. Further, the rising awareness about allergies, along with the growing prevalence of cardiac arrests among people is another significant factor that is anticipated to push the market growth further throughout the forecast period in the region.

Europe Market Forecast

Further, the Europe epinephrine market is projected to display notable growth over the forecast period on the back of the escalating prevalence of cardiovascular disorders, along with a surging ratio of anaphylaxis in the region. For instance, in Europe, cardiovascular disorders continue to be the main cause of death, contributing to almost 47% of all mortalities. Every year, more than 5 million people die from cardiovascular disorders in the European region. Additionally, the surge in technological advanced products is another major factor that is projected to spur the epinephrine market size over the projected time frame in the region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of epinephrine is evaluated at USD 1.37 billion.

The epinephrine market size was over USD 1.25 billion in 2024 and is likely to exceed USD 5.77 billion by the end of 2037, witnessing over 12.3% CAGR during the forecast period i.e., between 2025-2037. Upsurge in chronic respiratory disorders, growing occurrence of several types of allergic reactions, escalation in cardiac arrests will drive the market growth.

North America is predicted to account for largest industry share by 2037, attributed to escalating count of patients suffering from respiratory diseases such as asthma, coupled with rapidly expanding population in the region.

The major players in the market include Teva Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Pfizer Inc., kaleo, Inc., ALK-Abelló A/S, Bausch Health Companies Inc., Viatris Inc., Abbott Laboratories.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample